Procter & Gamble Health Ltd

  • BSE Code : 500126
  • NSE Symbol : PGHL
  • ISIN : INE199A01012
  • Industry :PHARMACEUTICALS - MULTINATIONAL

up-arrow 6,217.00 321.50(5.45%)

Open Price ()

5,895.50

Prev. Close ()

5,895.50

Volume (No’s)

241,190

Market Cap ()

10,319.84

Low Price ()

5,895.50

High Price ()

6,500.00

 

Book Closure

From Date To Date Announcement
01-Aug-2025 NA Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2025 inter alia to consider and approve Dear Sir We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday August 1 2025 inter alia to consider and approve unaudited Financial Results for the quarter ended June 30 2025. Please find attached outcome of Board meeting dated August 1, 2025. Please find attached unaudited financial results for quarter ended June 30, 2025. (As Per BSE Announcement Dated on :01.08.2025)
29-May-2025 NA Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 inter alia to consider and approve Audited Financial Statements for the Financial Year ended March 31 2025 and to consider recommendation of dividend (if any). We are pleased to inform you that a meeting of the Board of Directors of the Company held today (commenced at 12.40 pm and ended at 5.14 pm), the Audited Financial Results for the Financial Year ended March 31,2025 were approved. Find enclosed: a. Audited Financial Results for the Financial Year ended March 31,2025, b. Auditor's Report, in respect of the aforementioned Financial Results, c. A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results We are pleased to further inform you that the Board of Directors of the Company at its meeting held today, inter alia, have recommended a dividend of Rs. 45 per Equity Share, for the Financial Year ended March 31, 2025. The divided shall be paid on or before September 25, 2025, on approval of the Members at the ensuing Annual General Meeting (As Per BSE Announcement dated on 29.05.2025)
09-Apr-2025 11-Apr-2025 Dear Sir, Please find attached notice of postal ballot along with postal ballot form, for seeking approval of the members of the Company on the agenda items mentioned in the postal ballot notice. POM 11/04/2025 (As Per BSE Bulletin Dated on 10.03.2025) Dear Sir, Please find attached proceedings of the postal ballot along with results and scrutinizers report. Request you to kindly take the same on record. (As Per Bse Announcement Dated on 10.04.2025)
01-Apr-2025 NA Find enclosed communication with respect to change in directorate Find enclosed communication with respect to appointment of chairperson of the Board. We are pleased to inform you that the shareholders of the Company have approved resolution for appointment of Mr. Sharad Tyagi and Ms. Krishna Sarma as Independent Director of the Company, effective April 1, 2025. Request you to kindly take the same on record. (As Per Bse Announcement Dated on 10.04.2025)
31-Mar-2025 NA Find enclosed communication with respect to change in directorate-retirement

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew